HCPCS Level II code C1725 represents a non-laser transluminal angioplasty catheter, a device used in endovascular procedures to dilate vascular narrowings and potentially deliver fluids or therapeutic agents. This code is significant nationally because it identifies a commonly utilized class of angioplasty device in peripheral and vascular interventions, impacting device billing, hospital supply management, and procedural coding consistency across payers.

Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of clinical context for device use, common billing considerations, and what to expect from payer coverage patterns. The publication summarizes benchmarking points and policy-relevant items affecting device coding and reimbursement, and highlights typical sites of service where this device is billed.

The report provides practical reference material: code definition and clinical role, payer coverage landscape, common modifiers and billing considerations (listed elsewhere in the publication), and pointers to related device and procedure coding. Where input data were not provided, the publication notes the absence of that specific information. The content is written for a national audience of coding professionals, practice managers, and policy analysts seeking a clear, concise overview of HCPCS Level II code C1725 and its place in endovascular procedure billing.